The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro
- PMID: 8405030
- DOI: 10.1007/BF00315350
The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro
Abstract
The effects of sodium nitroprusside (SNP) and 3-morpholino sydnonimine (SIN-1), isosorbide dinitrate (ISDN) and glyceryl trinitrate (GTN), and molsidomine (the inactive precursur of SIN-1) on monocyte chemotaxis and cyclic GMP (cGMP) concentration were studied. SNP and SIN-1 inhibited monocyte N-formyl-methionyl-leucyl-phenylalanine-stimulated migration and increased cGMP concentrations in a dose-dependent (> 10(-5) mol.l-1) and time-dependent manner. Furthermore, 8-bromo cGMP inhibited monocyte chemotaxis in a dose-dependent fashion. In contrast, ISDN, GTN and molsidomine did not alter monocyte migration or cGMP concentration. These results support earlier observations that nitric oxide inhibits monocyte function in vitro via a cGMP-mediated mechanism. The differential effects of the spontaneous and thiol-dependent NO-donating nitrovasodilators on monocyte function suggests that monocytes, like platelets, are not able to directly metabolise ISDN and GTN. If similar observations can be made in vivo, it is possible that certain nitrovasodilators might be used therapeutically to inhibit monocyte function, for example during atherogenesis.
Similar articles
-
Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.Eur J Pharmacol. 1990 Jul 3;182(2):211-8. doi: 10.1016/0014-2999(90)90279-f. Eur J Pharmacol. 1990. PMID: 1697805
-
Nitrovasodilator-induced inhibition of LTB4 release from human PMN may be mediated by cyclic GMP.Eicosanoids. 1990;3(4):243-5. Eicosanoids. 1990. PMID: 1963541
-
Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro.Br J Pharmacol. 2004 Feb;141(4):653-60. doi: 10.1038/sj.bjp.0705661. Epub 2004 Jan 26. Br J Pharmacol. 2004. PMID: 14744805 Free PMC article.
-
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure.Int J Cardiol. 1990 Feb;26(2):175-84. doi: 10.1016/0167-5273(90)90031-y. Int J Cardiol. 1990. PMID: 2105912 Review.
-
Nitric oxide and related vasodilators.Can J Anaesth. 1997 May;44(5 Pt 2):R23-33. doi: 10.1007/BF03022262. Can J Anaesth. 1997. PMID: 9196837 Review. English, French. No abstract available.
Cited by
-
Endothelial nitric oxide synthase polymorphisms and hypertension.Curr Hypertens Rep. 2003 Feb;5(1):19-25. doi: 10.1007/s11906-003-0006-0. Curr Hypertens Rep. 2003. PMID: 12530931 Review.
-
Exercise and nitric oxide prevent bubble formation: a novel approach to the prevention of decompression sickness?J Physiol. 2004 Mar 16;555(Pt 3):825-9. doi: 10.1113/jphysiol.2003.055467. Epub 2004 Jan 14. J Physiol. 2004. PMID: 14724207 Free PMC article.
-
Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.Am J Pathol. 1999 Aug;155(2):591-8. doi: 10.1016/S0002-9440(10)65154-1. Am J Pathol. 1999. PMID: 10433951 Free PMC article.
-
Recent developments in nitric oxide donor drugs.Br J Pharmacol. 2007 Jun;151(3):305-21. doi: 10.1038/sj.bjp.0707224. Epub 2007 Apr 2. Br J Pharmacol. 2007. PMID: 17401442 Free PMC article. Review.
-
Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation.Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8006-11. doi: 10.1073/pnas.141136098. Epub 2001 Jun 26. Proc Natl Acad Sci U S A. 2001. PMID: 11427723 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources